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IFN-a Enhances Poly-IC Responses in Human
Keratinocytes by Inducing Expression of Cytosolic
Innate RNA Receptors: Relevance for Psoriasis
Errol P. Prens1,2, Marius Kant2, Grietje van Dijk2, Leontine I. van der Wel1,2, Sabine Mourits2 and
Leslie van der Fits1,2
Keratinocytes play a key role in innate immune responses of the skin to bacterial and viral pathogens. Viral
double-stranded RNA and its synthetic analogue polyriboinosinic-polyribocytidylic acid (poly-IC) are
recognized via multiple pathways involving the receptors Toll-like receptor 3 (TLR3), protein kinase R (PKR),
and the recently described cytosolic RNA helicases retinoic acid-inducible gene-I (RIG-I) and melanoma
differentiation-associated gene 5 (MDA5). We show that preincubation of human keratinocytes with IFN-a
enhances the proinflammatory responses to poly-IC. Kinetic studies suggest that this is mediated via
upregulation of the receptors TLR3, PKR, RIG-I, and MDA5. Interestingly, expression of RIG-I, MDA5, and PKR
was significantly increased in lesional skin from patients with psoriasis, a chronic inflammatory skin disease that
is characterized by high IFN-a levels. These results suggest that psoriatic keratinocytes show increased
sensitivity to viral RNA intermediates, thereby leading to excessive proinflammatory responses and
maintenance of the inflammatory skin phenotype. Here, we provide early evidence that point toward a role
for the recently described cytosolic innate RNA receptors in non-viral chronic inflammatory diseases.
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INTRODUCTION
Pattern recognition receptors are germline-encoded mole-
cules that play a crucial role in innate immune responses
against microorganisms by recognizing pathogen-associated
molecular patterns (PAMPs). In the past, main interest has
been focused on members of the Toll-like receptor (TLR)
family, pattern recognition receptors that are expressed on
the cell surface, or on lysosomal/endosomal membranes
(Takeda et al., 2003). Recently, cytoplasmic sensors of
PAMPs were identified. These include the nucleotide-binding
oligomerization domain-like receptors (also known as NOD-
LRR, NACHT-LRR, and CATERPILLER) and the retinoic acid-
inducible gene (RIG)-like helicases (also known as CARD
helicases and RNA helicases). These protein families have
been implicated in the recognition of bacterial and viral
components, respectively (reviewed in Meylan et al., 2006).
The skin, as outermost part of the body, provides the first
line of defense against invading pathogens. Besides forming a
physical barrier with a hard-to-penetrate stratum corneum,
the epidermis is a key component of innate immunity. Kera-
tinocytes (KCs), the major cell type present in the epidermis,
can exert many immunological functions such as cytokine
and chemokine production, cell adhesion, and antigen
presentation, and can therefore be regarded as immune-
competent cells. KCs are responsive to stimulation with
various PAMPs, and TLR expression on human KCs has been
studied extensively (Song et al., 2002; Baker et al., 2003;
Curry et al., 2003; Mempel et al., 2003; Pivarcsi et al., 2003;
Kollisch et al., 2005; Tohyama et al., 2005; Lebre et al.,
2007). In contrast, very little is known about KCs expression
of members of the other families of pattern recognition
receptor families such as the NOD-like receptors or the RIG-
like helicases. Polyriboinosinic-polyribocytidylic acid (poly-
IC), a synthetic analogue of viral double-stranded RNA
(dsRNA), is one of the most potent PAMPs for human KCs
(Kollisch et al., 2005; Lebre et al., 2007). DsRNA is a
common by-product of viral replication. Viral products can
be detected in healthy human skin and in samples from
various pathological skin conditions such as skin cancers and
inflammatory skin diseases such as psoriasis.
Pretreatment of human macrophages with the antiviral
protein IFN-a results in enhancement of TLR-mediated
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induction of antiviral cytokines (Siren et al., 2005). In addi-
tion, IFN-a sensitization of human epidermal, endothelial,
and epithelial cells results in a more pronounced poly-IC-
induced apoptotic and antiviral response (Kaiser et al., 2004;
Tissari et al., 2005; Tohyama et al., 2005). Together these
results suggest a role for IFN-a in enhancing innate immune
responses triggered by various PAMPs.
In this study we show that pretreatment of human KCs
with IFN-a results in augmentation of poly-IC-induced
proinflammatory responses, and that this effect is likely due
to induction of the expression of various dsRNA receptors.
Clinical relevance of these findings is illustrated by the
observation that expression of these receptors is significantly
increased in psoriatic KCs.
RESULTS
Poly-IC induces a strong proinflammatory response in human
KCs
KCs can produce a plethora of cytokines, for example IL-6,
a multifactorial cytokine that regulates immune responses
and inflammation. Increased IL-6 levels are detectable in
inflamed skin lesions from psoriasis patients, and therefore
IL-6 was used in this study as a signature cytokine of
inflamed KCs. The effect of various bacterial and viral PAMPs
(lipopolysaccharide (LPS) and peptidoglycan (PGN), and
poly-IC, respectively) on the production of IL-6 was assayed
using KCs (both primary and HaCaT cells) and primary
dermal fibroblasts. We observed that IL-6 was induced
strongly in human KCs after stimulation with poly-IC, where-
as IL-6 production was hardly increased upon stimulation
with LPS and PGN. In contrast, in human dermal fibroblasts
the expression of IL-6 was increased after stimulation with
both poly-IC and LPS (Figure 1). The effect of poly-IC on the
production of other proinflammatory cytokines and chemo-
kines was further investigated. Stimulation of HaCaT cells
or primary KCs with poly-IC resulted in a strong induction of
IL-8, IL-1a, IL-1b, and IFN-b (data not shown). In addition,
mRNA expression of the proinflammatory chemokines
CCL2, CCL3, CCL4, CCL5, CCL20, CXCL10, and CXCL11
was strongly increased by poly-IC (data not shown).
KCs are capable of expressing immunostimulatory mole-
cules that are involved in cell adhesion and antigen presen-
tation. We assessed the effect of poly-IC on the expression of
ICAM-1 (CD54) and HLA-DR on HaCaT cells and primary
KCs by flow cytometry. Poly-IC caused a strong increase in
ICAM-1 expression, whereas the expression of HLA-DR was
hardly affected (Figure 2). In contrast, both ICAM-1 and HLA-
DR expression was strongly increased upon stimulation with
IFN-g, as demonstrated previously (van der Fits et al., 2004).
In summary, in human KCs, poly-IC causes a strong induc-
tion of key proinflammatory cytokines and chemokines, as
well as of the adhesion molecule ICAM-1.
IFN-a sensitization of human KCs augments poly-IC-induced
proinflammatory responses
Recent literature shows that the responses elicited by various
PAMPs can be augmented by pretreatment of cells with IFN-a
(Kaiser et al., 2004; Siren et al., 2005; Tissari et al., 2005;
Tohyama et al., 2005). We therefore assessed whether IFN-a
is able to enhance the poly-IC-induced IL-6 and ICAM-1
expression. HaCaT cells were pretreated with different
doses of IFN-a for 16 hours, and subsequently stimulated
for 24 hours with poly-IC. A dose-dependent augmentation
of poly-IC-induced IL-6 secretion and ICAM-1 expression
was observed, with a maximum increase at 500U/ml IFN-a
(Figure 3a and b). At this concentration, the augmentation of
IL-6 and ICAM-1 expression was statistically significant
(Po0.05; non-parametric Wilcoxon’s paired test, n is equal
to at least five independent experiments). Moreover in
primary KCs, IFN-a pretreatment resulted in increased poly-
IC-induced IL-6 secretion (n¼3 with primary KC cultures
from different donors). In contrast, IFN-a pretreatment of
HaCaT cells or primary KC cultures did not result in consis-
tent induction of responses to LPS or PGN (Figure 3c).
IFN-a sensitization of human KCs is likely due to increased
expression of dsRNA receptors
To dissect the mechanism involved in the IFN-a sensitization
of poly-IC responses, kinetic analysis was performed. HaCaT
cells were pretreated with 500U/ml IFN-a for various time
periods, and subsequently stimulated for 24 hours with poly-
IC. Simultaneous addition of poly-IC and IFN-a (i.e. 0 hour
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Figure 1. Poly-IC induces IL-6 expression in human KCs. HaCaT KCs,
primary KCs, or primary dermal fibroblasts were stimulated for 24 hours with
1mg/ml LPS, 10 mg/ml PGN or 100 ng/ml poly-IC, or cultured in medium
alone (med). Secretion of IL-6 in the culture supernatant was determined by
ELISA. Results are presented as mean7SD of duplicate measurements. Similar
results were obtained with primary KCs and fibroblasts obtained from a
different donor.
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Figure 2. Poly-IC differentially induces the expression of molecules involved
in cell adhesion and antigen presentation, when compared to IFN-c. HaCaT
cells were cultured in medium alone (filled graphs), treated for 24 hours with
10mg/ml poly-IC (black lines), or 500U/ml IFN-g (gray lines), and analyzed
for expression of ICAM-1 and HLA-DR by flow cytometry. Representative
experiments from at least 2 are shown. Identical results were obtained with
primary KC cultures (data not shown).
www.jidonline.org 933
EP Prens et al.
Cytosolic Innate RNA Receptors in Psoriasis
IFN-a pretreatment) did not result in enhancement of poly-IC-
induced IL-6 production. However, as illustrated in Figure 4,
preincubation with IFN-a for 16 hours was required for
optimal augmentation of poly-IC-induced IL-6 production.
Similar kinetics was observed for the production of IL-8 (data
not shown).
To study the contribution of the different receptors for
dsRNA to the IFN-a sensitization effect in human KCs, we
examined mRNA expression of TLR3, protein kinase R (PKR),
and the RNA helicase proteins RIG-I and melanoma differen-
tiation-associated gene 5 (MDA5). In HaCaT cells, the expres-
sion of all receptors studied was rapidly induced by IFN-a,
although the level of induction differed for the various recep-
tors (Figure 5). The kinetics of induction was very similar for
all receptors studied: a maximal induction was observed
4–8 hours after the addition of IFN-a. Identical results were
obtained with freshly isolated epidermal cells (data not
shown).
In conclusion, our data on the kinetics of IFN-a sensitiza-
tion (Figure 4), together with the rapid induction of dsRNA
receptors by IFN-a (Figure 5), suggest that the IFN-a-induced
sensitization to poly-IC stimulation in human KCs is mediated
via upregulation of the endosomal/lysosomal receptor TLR3,
as well as the cytosolic innate RNA receptors PKR, RIG-I, and
MDA5.
Increased RIG-I, MDA5, and PKR expression in psoriatic
plaques
We demonstrated previously that in psoriatic plaques the
IFN-a signaling pathway is activated (van der Fits et al.,
2004), probably due to increased expression of type I
IFNs (Schmid et al., 1994; Nardelli et al., 2002). We there-
fore hypothesized that psoriatic KC show increased expres-
sion of the different dsRNA receptors. Quantitative mRNA
expression of these receptors was determined in RNA
extracted from epidermal cells isolated from healthy control
skin (NN), non-lesional (PN), or lesional skin (PP) from psoria-
sis patients. Although the expression of TLR3 was unaltered
in lesional skin of psoriasis patients, a significant increase in
RIG-I, MDA5, and PKR mRNA expression was observed (non-
parametric Mann–Whitney U-test; Figure 6). Non-lesional skin
from psoriasis patients did not show an aberrant expression of
PKR, RIG-I, and MDA5. Surprisingly, a significant reduction in
TLR3 expression was detected (Figure 6).
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Figure 3. IFN-a enhances the proinflammatory response of poly-IC in HaCaT
cells and primary KCs. HaCaT cells were pretreated with various doses of
IFN-a for 16 hours, and subsequently stimulated with 1mg/ml poly-IC.
(a) Secretion of IL-6 in the supernatant was determined by ELISA, and (b) the
percentage of cells positive for ICAM-1 expression was determined by flow
cytometry. (c) HaCaT cells or primary KCs were pretreated with 500U/ml
IFN-a for 16 hours, and subsequently stimulated for 24 hours with 1 mg/ml LPS,
10mg/ml PGN, and 100ng/ml poly-IC. Secretion of IL-6 in the supernatant
was determined by ELISA. Representative experiments are shown.
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Figure 4. Preincubation with IFN-a for at least 16 hours shows optimal
augmentation of poly-IC responses. HaCaT cells were preincubated with
500U/ml IFN-a for the periods indicated in the figure, and subsequently
stimulated with poly-IC for 24 hours. IL-6 secretion in the culture supernatant
was determined by ELISA, expressed relative to values secreted by untreated
cells, and presented mean7SD of duplicate measurements. A representative
experiment of 4 is shown.
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Figure 5. IFN-a rapidly and transiently induces the expression of all known
receptors for dsRNA. TLR3, RIG-I, MDA5, PKR, and GAPDH mRNA
expression was determined by quantitative RT-PCR in cDNA samples isolated
from HaCaT cultured with 500U/ml IFN-a for the time points indicated.
mRNA levels were calculated relative to a standard sample, and standardized
for GAPDH. Target gene expression was calculated as fold-induction relative
to the expression measured in cells cultured in medium not supplemented
with IFN-a, and presented as mean7SD of duplicate measurements.
A representative experiment of 2 is shown.
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Immunohistochemical analysis of skin biopsies from
healthy, non-lesional, and lesional psoriasis skin confirmed
increased expression of RIG-I and MDA5 in psoriatic plaques
on the protein level (Figure 7). RIG-I protein expression was
detected in KCs present in psoriasis lesional skin, but not in
normal skin samples or non-lesional skin, similar to as
demonstrated very recently (Kitamura et al., 2007). In healthy
skin and non-lesional psoriasis skin, MDA5 protein expres-
sion was immunohistochemically detectable, mainly in KCs
present in the basal cell layer. In lesional psoriasis skin,
however, MDA5 expression was additionally detectable in
KCs present in suprabasal cell layers (Figure 7). Furthermore,
strong MDA5 protein expression was detected in another,
yet undefined, cell type that is predominantly located in
the dermis of healthy, non-lesional, and lesional psoriasis
skin. Unfortunately, we were unable to detect TLR3 and
PKR protein expression in healthy or psoriasis skin biopsies
by immunohistochemistry (data not shown). Similarly, mini-
mal TLR3 staining was demonstrated previously in healthy
and psoriatic skin using two different antibodies (Baker et al.,
2003).
DISCUSSION
In this study, we demonstrate that proinflammatory poly-IC
responses in human KCs are augmented by IFN-a pretreat-
ment. The underlying mechanism includes the induction of
expression of the receptors that recognize dsRNA. Clinical
relevance of this finding is illustrated by the observation that
expression of these receptors is significantly increased in
psoriasis lesional skin. Although the expression of family
members of the TLR family was studied extensively in human
KCs and psoriatic skin (Song et al., 2002; Baker et al., 2003;
Curry et al., 2003; Mempel et al., 2003; Pivarcsi et al., 2003;
Kollisch et al., 2005; Lebre et al., 2007), minimal data are
available on the expression of the RNA helicases RIG-I and
MDA5 in KCs and inflamed skin.
The inflammatory skin disease psoriasis has been asso-
ciated with chronic viral infections (e.g. Yamamoto et al.,
1995; Erkek et al., 2000). In the skin lesions of the majority of
psoriasis patients, DNA from human papillomavirus types 5
and 36 is readily detectable, whereas only a small percentage
of healthy skin samples was positive (Favre et al., 1998;
Majewski et al., 1998; Prignano et al., 2005). In addition,
expression of human endogenous retroviruses was demon-
strated in a majority of psoriatic plaques (Bessis et al., 2004;
Moles et al., 2005). Nevertheless, a functional role for viral
products in the development and/or maintenance of psoriasis
has never been conclusively established. Results presented
in this study suggest that persistence of viral sequences in
psoriatic skin can continuously activate KCs via the different
dsRNA receptors. This might contribute to sustained high
expression of proinflammatory cytokines, chemokines, and
molecules involved in cell adhesion, thereby promoting a
continuous recruitment and activation of cells of the immune
system such as neutrophils, DC, macrophages, and (NK) T
cells, collectively contributing to the phenotypic alterations
that are typical for psoriatic plaques.
An emerging role for IFN-a in non-infectious inflammatory
skin diseases is becoming apparent. IFN-a production by
plasmacytoid DC is indispensable for the development of
psoriasis-like lesions in an human-onto-mice xenotransplant-
ation model (Nestle et al., 2005). We show that IFN-a stimu-
lation of human KCs induces the expression of all innate RNA
receptors. Furthermore, KCs from psoriasis lesional skin show
elevated expression of RIG-I, MDA5, and PKR, whereas
expression of TLR3 is unaltered. Since stimulation of human
KCs by IFN-a also upregulates TLR3 expression (Tohyama
et al., 2005; this paper), our data suggest that the level of
expression of the innate RNA sensors in psoriatic skin is not
solely determined by IFN-a, but that other regulatory
mechanisms or stimuli are important as well.
Although TLR3, RIG-I, MDA5, and PKR are all able to
recognize poly-IC, these receptors and signaling pathways
are not redundant. This is partly explained by a different
subcellular localization of the receptors: embedded in endo-
somal/lysosomal membranes (TLR3) or cytoplasmic (RIG-I,
MDA5, and PKR) (Meylan et al., 2006). Recently it was
demonstrated that RIG-I recognizes a distinct molecular
viral signature (unmodified 50-triphosphate single-stranded
RNA), which is not recognized by MDA5 (Hornung et al.,
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Figure 6. Epidermal cells from psoriatic plaques show increased expression
of RIG-I, MDA5, and PKR. mRNA levels of TLR3, RIG-I, MDA5, PKR,
and GAPDH were assayed in total RNA extracts from epidermal cells from
healthy donors (NN, n¼5) and non-lesional (PN, n¼6) and lesional skin
(PP, n¼ 7 or 9) from psoriatic patients. mRNA levels were calculated
relative to a standard sample, and standardized for GAPDH. Each symbol
represents the expression of TLR3, PKR, RIG-I, or MDA-5 mRNA for an
individual donor or patient, calculated relative to the mean expression level in
healthy skin. The median expression levels are indicated with horizontal
lines. P-values in the figure indicate significant differences.
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2006; Pichlmair et al., 2006), showing that these receptors
are selectively involved in the recognition of different
viral families. MDA5-deficient mice injected with poly-IC
showed completely abolished type I IFN production, whereas
IL-6 and IL-12p40 production was only partly inhibited,
demonstrating that poly-IC-induced production of various
antiviral and proinflammatory cytokines is differentially
regulated and is dependent on different dsRNA signaling
pathways (Kato et al., 2006). Furthermore, it was shown that
RIG-I and the TLR system exert antiviral responses in a cell
type-specific manner (Kato et al., 2005). Therefore, it would
be of great interest to assess the relative contribution of
the different dsRNA signaling pathways to the described
proinflammatory responses in human KCs. Blocking specific
dsRNA receptors with chemical inhibitors or siRNA will
provide insights into the functionality of the different
receptors.
It was previously shown that overexpression of RIG-I
in bronchial epithelial cells results in increased induction
of IP-10 in response to poly-IC (Taima et al., 2006). There-
fore, it is conceivable that KCs in skin from psoriasis patients
show a stronger response to dsRNA, due to increased receptor
expression. Unfortunately, it is impossible to quantitatively
compare poly-IC responses between KC from healthy and
psoriatic skin, since many proinflammatory markers are already
highly upregulated in cultured psoriatic KC, for example IL-6
(Grossman et al., 1989; Debets et al., 1995), IL-1a, IL-1b
(Debets et al., 1995), and ICAM-1 (our unpublished data).
In conclusion, KCs present in lesional skin from psoriasis
patients might be more susceptible to triggering by viral
PAMPs due to increased expression of different receptors that
recognize viral RNA intermediates. This increased sensitivity,
combined with the constitutive presence of viral sequences in
psoriatic skin, might contribute to the maintenance of the
proinflammatory milieu that is underlying the histological
and clinical abnormalities of the psoriatic plaques.
MATERIALS AND METHODS
Donor and patient material
Human tissue samples were obtained after informed consent and
approval of the Medical Ethics Committee of the Erasmus MC, the
Netherlands. This study was performed according to the Declaration
of Helsinki Principles. Healthy skin samples were obtained from
adult donors undergoing plastic surgery (Sint Franciscus Hospital
Rotterdam and Erasmus MC, Rotterdam, the Netherlands). Skin
donors were considered healthy when having no (family) history of
skin diseases or other systemic disorders.
Lesional and non-lesional skin samples were taken from 16
patients with stable plaque-type psoriasis (Ziekenhuis Walcheren,
Vlissingen, the Netherlands). Before participation in this study,
psoriasis patients received no topical treatment for a period of at
least 3 weeks, and no systemic treatment for at least 2 months.
Cell isolation, culture, and stimulation
HaCaT, a spontaneously immortalized human KC cell line (Boukamp
et al., 1988), was cultured as described (van der Fits et al., 2004).
To obtain primary KC cultures, skin samples from healthy donors
were cut into small pieces and incubated onto a feeder layer of
irradiated mouse 3T3 fibroblasts in 25 cm2 flasks in KC growth
medium (DMEM/Ham’s F12 (2:1) (Cambrex, East Rutherford, NJ),
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Figure 7. Increased RIG-I and MDA5 protein expression in psoriasis lesional skin. Immunohistochemical analysis of RIG-I and MDA5 proteins in healthy
(NN, left row), non-lesional (PN, middle row), and lesional psoriatic (PP, right row) skin biopsies. Representative examples of at least three skin biopsies of each
type are depicted. Bar¼ 50mm.
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supplemented with 10% heat-inactivated fetal calf serum (BioWhit-
taker, Walkersville, MD) and 10ng/ml epidermal growth factor,
5mg/ml insulin, 500mg/ml transferrin, and 4mg/ml hydrocortisone
(all from Sigma, St Louis, MO)) at 371C and 5% CO2. When KCs were
grown to confluence, cells were transferred to 75 cm2 flasks. Primary
dermal fibroblast were grown from skin from healthy donors in
DMEM medium supplemented with 5% fetal calf serum until
confluence. Primary cells, both KCs and fibroblasts, were used in
passages 2–4. Epidermal cell suspensions were prepared from skin
shaves using standard methods (Prens et al., 1991).
Cells were stimulated with 1mg/ml LPS (Brunschwig, Amsterdam,
the Netherlands), 10 mg/ml PGN (prepared from Staphylococcus
aureus, as used in Visser et al., 2005, with a LPS content of
o13 pg/mg), 0.1–10mg/ml poly-IC (Amersham Biosciences,
Piscataway, NJ), 10–1000U/ml IFN-a (IntronA IFN-a2b, Schering-
Plough, Kenilworth, NJ), or 500U/ml IFN-g (Boehringer Ingelheim,
Heidelberg, Germany) for the incubation periods indicated.
ELISA
Culture supernatants were harvested, centrifuged for 5minutes at
1500 r.p.m., and stored at 201C until use. IL-6 levels were
determined by ELISA, according to the manufacturer’s instructions
(BioSource, Camarillo, CA), with a detection limit of o1pg/ml.
Flow cytometry
After stimulation, cells were detached with phosphate-buffered
saline containing 0.025% trypsin and 0.1% EDTA and washed
in phosphate-buffered saline. Flow cytometry was performed
using mouse a-ICAM-1-PE (1:4 dilution, BD Biosciences, Franklin
Lakes, NJ) or mouse a-HLA-DR-PE (1:20 dilution, BD Biosciences)
antibodies as described previously (van der Fits et al., 2004).
Quantitative RT-PCR
Total RNA was extracted from HaCaT, primary KCs, or epidermal
cell suspensions (1–2 106 cells) using the GenElute Mammalian
Total RNA kit (Sigma). Using 1 mg of the total RNA as template,
cDNA was obtained using the AMV Reverse Transcription System
(Promega, Madison, WI).
Real-time quantitative RT-PCR was performed as described
previously (van der Fits et al., 2003). DNA sequences of primers
(forward primer; reverse primer), and FAM-labeled probes were:
TLR3 (AGTTGTCATCGAATCAAATTAAAGAG, AATCTTCCAATTGC
GTGAAAA, and TCTCCAGG), RIG-I (TGTGGGCAATGTCATCAA
AA, GAAGCACTTGCTACCTCTTGC, and CAGAGGAA), MDA5
(GGCACCATGGGAAGTGATT, ATTTGGTAAGGCCTGAGCTG, and
GGAGCCAG), and PKR (TTTGGACAAAGCTTCCAACC, CGGTATGT
ATTAAGTTCCTCCATGA, and CAGCAGGT).
Probes were purchased from Exiqon (Vedbaed, Denmark).
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA
levels were measured as a control to normalize for RNA input using
a commercially available primer/probe mixture (PE-Applied Biosys-
tems, Foster City, CA).
Immunohistochemistry
Immunohistochemistry was performed as described previously (van
der Fits et al., 2004). Cryosections of healthy, non-lesional, and
lesional psoriatic skin were fixed in acetone and incubated with
primary goat IgG antibodies against human RIG-I (Santa Cruz
Biotechnology Inc., Santa Cruz, CA; 1:20) or MDA5 (Santa Cruz;
1:40) overnight at 41C. This was followed by incubation for
30minutes with biotin-linked secondary horse anti-goat antibody
and peroxidase-linked avidin (DAKO, Glostrup, Denmark). Per-
oxidase activity was revealed using 3-amino-9-ethylcarbazole
(Sigma) as chromogen, resulting in a bright red staining. Omission
of primary antibodies and sections incubated with isotype goat IgG
served as controls. Slides were counterstained with hematoxylin.
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